X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5793) 5793
Newspaper Article (58) 58
Newsletter (43) 43
Book Chapter (16) 16
Transcript (7) 7
Publication (4) 4
Conference Proceeding (3) 3
Magazine Article (2) 2
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5069) 5069
science & technology (4309) 4309
life sciences & biomedicine (4250) 4250
female (4160) 4160
carboplatin - administration & dosage (3617) 3617
oncology (3390) 3390
middle aged (3381) 3381
aged (3010) 3010
antineoplastic combined chemotherapy protocols - therapeutic use (2943) 2943
male (2822) 2822
carboplatin (2706) 2706
adult (2682) 2682
antineoplastic combined chemotherapy protocols - adverse effects (2519) 2519
carboplatin - adverse effects (2477) 2477
chemotherapy (2010) 2010
cancer (1569) 1569
treatment outcome (1471) 1471
paclitaxel - administration & dosage (1417) 1417
lung neoplasms - drug therapy (1267) 1267
neoplasm staging (967) 967
ovarian neoplasms - drug therapy (949) 949
carboplatin - therapeutic use (924) 924
carcinoma, non-small-cell lung - drug therapy (915) 915
antineoplastic agents - adverse effects (894) 894
aged, 80 and over (886) 886
disease-free survival (836) 836
cisplatin - administration & dosage (831) 831
drug administration schedule (828) 828
care and treatment (818) 818
paclitaxel - adverse effects (813) 813
paclitaxel (750) 750
antineoplastic combined chemotherapy protocols - administration & dosage (732) 732
combined modality therapy (724) 724
etoposide - administration & dosage (701) 701
survival rate (676) 676
ovarian cancer (674) 674
retrospective studies (663) 663
antineoplastic agents - therapeutic use (658) 658
lung neoplasms - pathology (590) 590
research (570) 570
cisplatin - adverse effects (561) 561
survival analysis (560) 560
antineoplastic agents - administration & dosage (525) 525
cisplatin (521) 521
pharmacology & pharmacy (521) 521
dose-response relationship, drug (494) 494
medicine & public health (488) 488
patients (477) 477
antineoplastic agents (463) 463
hematology, oncology and palliative medicine (462) 462
carcinoma, non-small-cell lung - pathology (453) 453
prognosis (451) 451
deoxycytidine - analogs & derivatives (449) 449
follow-up studies (449) 449
lung cancer (446) 446
cancer therapies (437) 437
adolescent (427) 427
antimitotic agents (423) 423
drug therapy (422) 422
obstetrics & gynecology (416) 416
analysis (412) 412
clinical trials (410) 410
deoxycytidine - administration & dosage (394) 394
lung neoplasms - mortality (391) 391
lung cancer, non-small cell (378) 378
toxicity (375) 375
cyclophosphamide - administration & dosage (373) 373
etoposide - adverse effects (360) 360
radiotherapy (358) 358
neoplasms - drug therapy (357) 357
hematology (356) 356
ovarian neoplasms - pathology (354) 354
prospective studies (354) 354
abridged index medicus (352) 352
child (349) 349
tumors (340) 340
health aspects (336) 336
metastasis (336) 336
neutropenia - chemically induced (329) 329
child, preschool (327) 327
thrombocytopenia - chemically induced (317) 317
chemotherapy, adjuvant (312) 312
neoplasm recurrence, local - drug therapy (312) 312
infusions, intravenous (307) 307
carcinoma, squamous cell - drug therapy (299) 299
carcinoma, non-small-cell lung - mortality (297) 297
surgery (291) 291
animals (289) 289
time factors (284) 284
kaplan-meier estimate (281) 281
risk factors (280) 280
remission induction (273) 273
infant (265) 265
oncology, experimental (264) 264
carboplatin - pharmacokinetics (262) 262
disease progression (262) 262
gemcitabine (262) 262
adenocarcinoma - drug therapy (258) 258
etoposide (258) 258
taxoids - administration & dosage (258) 258
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5641) 5641
Japanese (154) 154
German (70) 70
French (63) 63
Chinese (56) 56
Spanish (16) 16
Italian (13) 13
Russian (13) 13
Hungarian (5) 5
Portuguese (5) 5
Dutch (4) 4
Polish (3) 3
Bulgarian (2) 2
Czech (2) 2
Danish (2) 2
Korean (2) 2
Hebrew (1) 1
Norwegian (1) 1
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
... (n = 24) were 33% (95% CI, 16–55%) and 75%, respectively. Grade ≥ 3 treatment‐emergent adverse events, including anaemia, thrombocytopenia, lymphopenia... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Index Medicus | Haematological Malignancy | Research Paper
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 01/2015, Volume 33, Issue 1, pp. 13 - 21
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2018, Volume 36, Issue 4, pp. 383 - 390
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 09/2016, Volume 34, Issue 25, pp. 2969 - 2979
Journal Article
Pediatric neurology, ISSN 0887-8994, 07/2015, Volume 53, Issue 1, pp. 31 - 46
Journal Article
Human brain mapping, ISSN 1065-9471, 12/2012, Volume 33, Issue 12, pp. 2971 - 2983
.... Here, we investigated very late (>9 years) effects of adjuvant high-dose chemotherapy on brain white and gray matter in primary breast cancer survivors (n = 17... 
magnetic resonance imaging | multimodal MRI | proton MR spectroscopy | breast cancer | diffusion tensor imaging | side effects | voxel‐based morphometry | cognitive functioning | chemotherapy | Chemotherapy | Side effects | Cognitive functioning | Magnetic resonance imaging | Proton MR spectroscopy | Voxel-based morphometry | Breast cancer | Multimodal MRI | Diffusion tensor imaging | Neuroimaging | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Thiotepa - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Magnetic Resonance Imaging - methods | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Carboplatin - adverse effects | Carboplatin - therapeutic use | Time Factors | Chemotherapy, Adjuvant - adverse effects | Nerve Fibers, Myelinated - pathology | Nerve Fibers, Unmyelinated - drug effects | Female | Thiotepa - pharmacology | Nerve Fibers, Myelinated - drug effects | Survivors | Cognition - drug effects | Breast Neoplasms - drug therapy | Brain - drug effects | Neuropsychological Tests | Nerve Fibers, Unmyelinated - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Cyclophosphamide - pharmacology | Brain - pathology | Quality of Life | Aged | Carboplatin - pharmacology | Health Status | Thiotepa - adverse effects | Cancer survivors | Oncology, Experimental | Adjuvant treatment | Dosage and administration | Diagnostic imaging | Research | Tamoxifen | Creatine | Cancer | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 07/2013, Volume 122, Issue 4, pp. 499 - 506
Journal Article